Literature DB >> 11739070

Cognitive and psychomotor effects of paroxetine and sertraline on healthy elderly volunteers.

P M Furlan1, M J Kallan, T Ten Have, B G Pollock, I Katz, I Lucki.   

Abstract

The authors evaluated the cognitive and psychomotor effects of serotonin reuptake inhibitors in healthy elderly volunteers. Paroxetine, sertraline, and placebo were compared for 3 weeks of testing in a double-blind study with behavioral testing at baseline and at the end of each week. MANOVA models demonstrated no between-group differences; however, mixed-model random regression analyses revealed that Day 14 plasma paroxetine levels correlated negatively with delayed verbal recall and paired-associate learning scores. In contrast, plasma sertraline levels correlated positively with Day 7 immediate verbal recall, Day 14 tapping, and Day 21 delayed verbal recall scores, and negatively with divided-attention task scores on Day 21. Plasma paroxetine levels were associated with mild behavioral impairment at Day 14, with no other significant adverse effects. Plasma sertraline levels were associated with mild and transient behavioral changes, as well as early termination in several subjects.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11739070

Source DB:  PubMed          Journal:  Am J Geriatr Psychiatry        ISSN: 1064-7481            Impact factor:   4.105


  12 in total

Review 1.  Serotonergic modulation of hippocampal theta activity in relation to hippocampal information processing.

Authors:  María Esther Olvera-Cortés; Blanca Erika Gutiérrez-Guzmán; Elisa López-Loeza; J Jesús Hernández-Pérez; Miguel Angel López-Vázquez
Journal:  Exp Brain Res       Date:  2013-08-30       Impact factor: 1.972

2.  Bupropion normalizes cognitive performance in patients with depression.

Authors:  C Thomas Gualtieri; Lynda G Johnson
Journal:  MedGenMed       Date:  2007-01-31

3.  Exploration of 100 commonly used drugs and supplements on cognition in older adults.

Authors:  Karen R Obermann; John C Morris; Catherine M Roe
Journal:  Alzheimers Dement       Date:  2013-08-15       Impact factor: 21.566

4.  Change in cognitive functioning in depressed older adults following treatment with sertraline or nortriptyline.

Authors:  Michelle E Culang-Reinlieb; Joel R Sneed; John G Keilp; Steven P Roose
Journal:  Int J Geriatr Psychiatry       Date:  2011-09-15       Impact factor: 3.485

Review 5.  Paroxetine-The Antidepressant from Hell? Probably Not, But Caution Required.

Authors:  Robert M Nevels; Samuel T Gontkovsky; Bryman E Williams
Journal:  Psychopharmacol Bull       Date:  2016-03-01

6.  Cognitive outcomes after sertaline treatment in patients with depression of Alzheimer disease.

Authors:  Cynthia A Munro; Crystal Flynn Longmire; Lea T Drye; Barbara K Martin; Constantine E Frangakis; Curtis L Meinert; Jacobo E Mintzer; Anton P Porsteinsson; Peter V Rabins; Paul B Rosenberg; Lon S Schneider; Daniel Weintraub; Constantine G Lyketsos
Journal:  Am J Geriatr Psychiatry       Date:  2012-12       Impact factor: 4.105

7.  Change in cognitive functioning following acute antidepressant treatment in late-life depression.

Authors:  Michelle E Culang; Joel R Sneed; John G Keilp; Bret R Rutherford; Gregory H Pelton; D P Devanand; Steven P Roose
Journal:  Am J Geriatr Psychiatry       Date:  2009-10       Impact factor: 4.105

8.  Cortisol, moderated by age, is associated with antidepressant treatment outcome and memory improvement in Major Depressive Disorder: A retrospective analysis.

Authors:  Felipe A Jain; Colm G Connolly; Victor I Reus; Dieter J Meyerhoff; Tony T Yang; Synthia H Mellon; Scott Mackin; Christina M Hough; Alexandra Morford; Owen M Wolkowitz
Journal:  Psychoneuroendocrinology       Date:  2019-07-26       Impact factor: 4.905

9.  Effects of serotonergic and noradrenergic antidepressants on auditory startle response in patients with major depression.

Authors:  Boris B Quednow; Kai-Uwe Kühn; Richard Stelzenmuelle; Klaus Hoenig; Wolfgang Maier; Michael Wagner
Journal:  Psychopharmacology (Berl)       Date:  2004-10       Impact factor: 4.530

Review 10.  The pharmacological management of depression.

Authors:  David J Kupfer
Journal:  Dialogues Clin Neurosci       Date:  2005       Impact factor: 5.986

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.